JP2017521389A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521389A5
JP2017521389A5 JP2016572703A JP2016572703A JP2017521389A5 JP 2017521389 A5 JP2017521389 A5 JP 2017521389A5 JP 2016572703 A JP2016572703 A JP 2016572703A JP 2016572703 A JP2016572703 A JP 2016572703A JP 2017521389 A5 JP2017521389 A5 JP 2017521389A5
Authority
JP
Japan
Prior art keywords
protein
tnfr
fusion protein
chromatography column
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017521389A (ja
JP6747985B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2015/054494 external-priority patent/WO2015189832A1/en
Publication of JP2017521389A publication Critical patent/JP2017521389A/ja
Publication of JP2017521389A5 publication Critical patent/JP2017521389A5/ja
Application granted granted Critical
Publication of JP6747985B2 publication Critical patent/JP6747985B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572703A 2014-06-13 2015-06-13 TNFR:Fc融合タンパク質の精製方法 Expired - Fee Related JP6747985B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1919MU2014 2014-06-13
IN1919/MUM/2014 2014-06-13
PCT/IB2015/054494 WO2015189832A1 (en) 2014-06-13 2015-06-13 Process for the purification of tnfr:fc fusion protein

Publications (3)

Publication Number Publication Date
JP2017521389A JP2017521389A (ja) 2017-08-03
JP2017521389A5 true JP2017521389A5 (https=) 2018-07-19
JP6747985B2 JP6747985B2 (ja) 2020-08-26

Family

ID=53524922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572703A Expired - Fee Related JP6747985B2 (ja) 2014-06-13 2015-06-13 TNFR:Fc融合タンパク質の精製方法

Country Status (12)

Country Link
US (1) US10556942B2 (https=)
EP (1) EP3155009A1 (https=)
JP (1) JP6747985B2 (https=)
CN (1) CN106536565A (https=)
AU (1) AU2015273049B2 (https=)
BR (1) BR112016029157A8 (https=)
CA (1) CA2951766A1 (https=)
MA (1) MA40232A (https=)
MX (1) MX2016016318A (https=)
PH (1) PH12016502482A1 (https=)
RU (1) RU2698654C2 (https=)
WO (1) WO2015189832A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3268042B1 (en) * 2015-03-13 2024-11-27 Samsung Bioepis Co., Ltd. Anti-tnf-alpha polypeptide composition and use thereof
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
EP3668985B1 (en) * 2017-08-17 2021-06-16 Just-Evotec Biologics, Inc. Method of purifying glycosylated protein from host cell galectins and other contaminants
JP2020531557A (ja) * 2017-08-30 2020-11-05 アレス トレーディング ソシエテ アノニム タンパク質の精製方法
US11952399B2 (en) * 2018-12-18 2024-04-09 Amgen Inc. Methods for purifying proteins
JP2022523063A (ja) * 2019-01-30 2022-04-21 アムジエン・インコーポレーテツド アフリベルセプトの属性、並びにその特性決定及び修飾方法
KR102286892B1 (ko) * 2019-07-08 2021-08-06 삼천당제약주식회사 안과용 단백질 제제의 정제방법
CN112876567A (zh) * 2019-11-29 2021-06-01 广东菲鹏制药股份有限公司 Fc融合蛋白及其纯化方法
EP4118093A4 (en) * 2020-03-11 2024-04-17 Dr. Reddy's Laboratories Ltd. METHOD FOR PURIFYING A FC FUSION PROTEIN
CN113563469A (zh) * 2020-04-28 2021-10-29 江苏中新医药有限公司 高回收率纯化阿达木单抗的方法
WO2022234412A1 (en) * 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins
AU2022358612A1 (en) * 2021-09-28 2024-04-11 Kashiv Biosciences, Llc An improved process of purification of fusion protein
EP4408856A4 (en) * 2021-09-28 2025-11-12 Kashiv Biosciences Llc IMPROVED PROCESS FOR PROTEIN PURIFICATION
US20240400612A1 (en) * 2021-09-28 2024-12-05 Kashiv Biosciences, Llc An improved process for purification of fusion protein
CN118414350A (zh) * 2021-10-19 2024-07-30 阿特根公司 纯化具有igg fc结构域的融合蛋白的方法
EP4435107A4 (en) * 2021-11-29 2025-12-31 Tosoh Corp ANTIBODY ISOLATION METHOD
CN119060168A (zh) * 2024-09-26 2024-12-03 广东丸美生物技术股份有限公司 一种具有低电导率的重组胶原蛋白溶液及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2021284C1 (ru) * 1991-05-30 1994-10-15 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Способ очистки клинических фракций декстрана
US7294481B1 (en) 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
SI1478394T1 (sl) 2002-02-27 2008-12-31 Immunex Corp STABILIZIRAN TNFR-Fc SESTAVEK Z ARGININOM
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
WO2007109163A2 (en) * 2006-03-16 2007-09-27 Amgen Inc Wash buffer and method of using
JP2010501622A (ja) * 2006-08-28 2010-01-21 アレス トレーディング ソシエテ アノニム Fc−融合タンパク質の精製法
SI2061803T2 (sl) * 2006-08-28 2023-01-31 Ares Trading S.A. Postopek za čiščenje proteinov, ki vsebujejo FC
WO2009053360A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying an fc-containing protein
BRPI0908270A2 (pt) * 2008-02-29 2019-09-10 Biogen Idec Inc proteínas de fusão de imunoglobulinas purificadas e método para a sua purificação
BRPI0919879A2 (pt) * 2008-10-29 2016-02-16 Wyeth Llc métodos para purificação de moléculas de ligação a antígeno de domínio único
SG182553A1 (en) * 2010-01-22 2012-08-30 Boehringer Ingelheim Int Chromatographic method for purifying fc-containing proteins
US20140128577A1 (en) * 2011-06-24 2014-05-08 Dr. Reddy's Laboratories Limited Purification of chimeric protein
DK2729482T3 (en) * 2011-07-08 2018-05-07 Merck Sharp & Dohme PROCEDURE FOR CLEANING FC-FUSION PROTEIN
KR101454316B1 (ko) * 2011-08-17 2014-10-27 한화케미칼 주식회사 활성형 TNFR-Fc 융합 단백질을 제조하는 방법
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
SI2895188T1 (en) * 2012-09-11 2018-05-31 Coherus Biosciences, Inc. CORRECTED QUALITY ETHANERCEPT WITH HIGH QUALITY AND EXCELLENT EXPERIENCE
CN102911250B (zh) * 2012-09-29 2014-04-16 浙江海正药业股份有限公司 酸性重组蛋白药物的纯化方法
WO2014078627A1 (en) * 2012-11-19 2014-05-22 Merck Sharp & Dohme Corp. Liquid formulations for tnfr:fc fusion proteins
SI3395423T1 (sl) * 2013-03-14 2023-12-29 Amgen Inc. Odstranjevanje izluženega liganda za afinitetno čiščenje
US8946395B1 (en) * 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography

Similar Documents

Publication Publication Date Title
JP2017521389A5 (https=)
RU2017100005A (ru) Способ очистки белка слияния
JP2018510867A5 (https=)
Spriestersbach et al. Purification of his-tagged proteins
Zhu et al. Hydrophilic-interaction chromatography of peptides on hydrophilic and strong cation-exchange columns
JP6092892B2 (ja) 抗体の精製方法
US10053489B2 (en) Method for purifying antibody
Furie et al. Interaction of lanthanide ions with bovine factor X and their use in the affinity chromatography of the venom coagulant protein of Vipera russelli
JP2014520814A5 (https=)
BRPI0611600B8 (pt) método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
Holstein et al. Improving selectivity in multimodal chromatography using controlled pH gradient elution
RU2453555C2 (ru) Способ очистки аполипопротеина а-1
US20200017545A1 (en) Methods and Reagents for Purification of Proteins
JP2015537212A5 (https=)
AU2012322949B2 (en) Protein purification by anion exchange chromatography
JP5883849B2 (ja) 陰イオン交換樹脂を用いる二価カチオン結合タンパク質の精製方法
CN104109202A (zh) 一种从血浆中吸附人凝血酶原复合物的方法
JP2016538264A (ja) 組換えタンパク質の精製方法
CN107793469A (zh) 一种去除宿主细胞蛋白含量的亲和纯化工艺
US12358946B2 (en) Method for purifying antibodies
CN103725664B (zh) 一种高度纯化激肽释放酶的方法
Xin et al. Development of universal purification protocols for fibrinolytic enzyme-producing bacilli
Ritzén et al. Endotoxin reduction in monoclonal antibody preparations using arginine
CN106496302B (zh) 一种用离子交换层析纯化蛋白质的方法
Ng et al. pH‐based cation exchange chromatography in the capture and elution of monoclonal antibodies